Anacor Pharmaceuticals, Inc. (ANAC) Posts Q3 Loss of $0.16, Sales Fall Y/Y

Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC) reported Q3 EPS of ($0.16), which may not compare to than the analyst estimate of ($0.41). Revenue for the quarter came in at $12.6 million, versus $16.9 million reported last year.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Movano (MOVE) Misses Q2 EPS by 195c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15